GCG and diabetes mellitus: As one of the major risk factors for CVD, DM may be treated with hypoglycemic medications such as sodium-dependent glucose transporter 2 inhibitor (SGLT2i) and glucagon-like peptide-1 (GLP-1) receptor agonist to lower cardiovascular events (28).